MedTrace Logo

Entral Feeding in Acute Severe Pancreatitis

NCT04406506 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-05-28

No results posted yet for this study

Summary

• A total of 60 patients admitted to King Abdulaziz Specialists Hospital between June 2018 and April 2020 with both a clinical and biochemical presentation of acute pancreatitis with the following inclusion criteria: Abdominal pain \> 6 on the visual analogue scale without given analgesia , abdominal distension and tenderness with serum amylase and serum lipase at least 3 times the upper limit of the reference range (considering normal lipase level from 0-160 U/L, and normal amylase level from 0-100 U/L) with confirmed abdominal computerized axial tomography of grade D and E on Ranson and colleagues criteria(28) of inflamed pancreatic picture.

Conditions

  • Postoperative Nausea

Interventions

DEVICE

nasogastric

• The insertion of NG tubes were performed by the ICU physician and the position was checked by auscultation of gas from 50 ml syringe by injecting 20 ml of air in the NG and by X-ray abdomen to be sure from the site of NG tube

DEVICE

nasojejunal

* The nasojejunal tube is silicone or polyurethane tube with an inner stylet that is positioned (under fluoroscopic guidance) beyond the ligament of Treitz. * Patients were placed in right lateral position

DRUG

(erythromycin 250 mg IV bolus)

prokinetic (erythromycin 250 mg IV bolus) given to assist the passage of the tube through the pylorus

Sponsors & Collaborators

  • King Abdul Aziz Specialist Hospital

    lead NETWORK

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-10
Primary Completion
2020-04-02
Completion
2020-04-10
FDA Drug
Yes

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04406506 on ClinicalTrials.gov